Biochemistry-informed design selects potent siRNAs against SARS-CoV-2.
Ontology highlight
ABSTRACT: RNA interference (RNAi) offers an efficient way to repress genes of interest, and it is widely used in research settings. Clinical applications emerged more recently, with 5 approved siRNAs (the RNA guides of the RNAi effector complex) against human diseases. The development of siRNAs against the SARS-CoV-2 virus could therefore provide the basis of novel COVID-19 treatments, while being easily adaptable to future variants or to other, unrelated viruses. Because the biochemistry of RNAi is very precisely described, it is now possible to design siRNAs with high predicted activity and specificity using only computational tools. While previous siRNA design algorithms tended to rely on simplistic strategies (raising fully complementary siRNAs against targets of interest), our approach uses the
SUBMITTER: Houbron E
PROVIDER: S-EPMC10243379 | biostudies-literature | 2023 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA